effect
streptococc
prepar
murin
fulmin
hepat
investig
hepat
induc
inject
mous
hepat
viru
type
strength
either
x
x
plaqueform
unit
pfu
mice
without
treatment
die
within
day
wherea
mice
preinocul
show
surviv
rate
x
pfu
loo
x
pfu
day
surviv
time
prolong
inject
examin
histolog
mice
treat
show
sever
haemorrhag
necrosi
liver
often
panlobular
treat
mice
show
less
necrosi
least
necrosi
observ
inject
mice
inject
first
x
pfu
surviv
day
autopsi
show
slight
focal
hepat
necrosi
follicular
infiltr
lymphocyt
macrophag
mitogen
reaction
spleen
cell
remark
less
normal
mice
inject
howev
mice
inject
treatment
mice
show
high
surviv
rate
show
rel
high
reactiv
comparison
mice
treat
mous
hepat
viru
mhv
member
coronaviru
group
belong
rna
virus
highli
transmiss
mhv
type
fulminantli
produc
massiv
necrosi
therefor
hepat
injuri
caus
may
good
model
studi
pathogenesi
human
fulmin
hepat
immunotherapi
use
biolog
respons
modifi
wide
appli
variou
field
cancer
treatment
also
appli
chronic
hepat
biolog
respons
modifi
streptococc
prepar
low
virul
sustrain
group
streptococcu
pyrogen
human
origin
incub
penicillin
g
potassium
known
produc
variou
immunolog
chang
includ
induct
interferon
activ
macrophag
activ
natur
killer
lymphocyt
effect
fulmin
hepat
mice
investig
surviv
time
histolog
chang
inocul
evalu
balbc
femal
spf
mice
week
old
obtain
charl
river
japan
inc
maintain
serial
passag
cultur
mous
cell
line
dbt
viru
purifi
plaqu
clone
propag
dbt
cell
cultur
fluid
harvest
infect
cell
cultur
incub
h
clarifi
centrifug
store
materi
assay
infect
plaqu
count
method
dbt
cell
indic
plaqu
form
unit
pfu
picibanil
chugai
pharmaceut
co
tokyo
japan
immunopotenti
develop
okamoto
et
al
produc
incub
penicillin
g
potassium
low
virul
sustrain
group
strepiococcu
pyrogen
human
origin
known
produc
variou
immunolog
chang
dissolv
physiolog
salin
use
mice
follow
inject
intraperiton
mice
group
b
c
x
pfumous
group
e
f
x
pfumous
dissolv
l
physiolog
salin
group
n
shown
fig
inject
intraperiton
group
ke
klinisch
einheit
head
day
day
inject
respect
kemous
inject
intraperiton
group
inject
group
b
everi
day
sinc
third
day
viru
inject
group
day
viru
inject
group
e
everi
day
viru
inject
surviv
mice
treat
group
c
sacrif
day
inject
mice
treat
group
c
surviv
day
inject
liver
mice
observ
macroscop
fix
formaldehyd
solut
embed
paraffin
variou
stain
perform
use
paraffin
section
microscop
observ
serum
glutam
oxaloacet
transaminas
sgot
examin
use
serum
mice
treat
group
b
c
first
day
inject
blastoid
format
spleen
cell
reaction
phytohaemagglutinin
pha
concanavalin
con
pwm
investig
use
normal
mice
n
mice
treat
group
c
ns
spleen
cell
obtain
asept
sacrif
mice
wash
time
rpmi
suspend
rpmi
contain
fetal
calf
serum
macroscop
liver
dead
mice
demonstr
mani
spotti
confluent
haemorrhag
necros
microscop
show
massiv
necros
fig
often
show
panlobular
necrosi
fig
howev
grade
hepat
necrosi
dead
mice
group
inocul
especi
group
gener
lower
mice
without
inocul
tabl
microscop
liver
sacrif
mice
treat
group
show
slight
patholog
chang
day
inject
scatter
focal
necros
accompani
follicular
lymphocyt
infiltr
mani
macrophag
day
inject
fig
tabl
slight
hepat
necrosi
day
inject
surviv
mice
slight
hepat
necrosi
congest
day
inject
confluent
hepat
necrosi
sublobular
level
day
inocul
mice
treat
group
c
way
dead
group
c
mice
sever
massiv
necrosi
liver
day
inject
level
sgot
group
mous
surviv
significantli
lower
mice
treat
group
b
c
day
p
fig
result
consist
histolog
find
time
cours
reaction
spleen
cell
mitogen
shown
fig
mice
inocul
react
remark
less
normal
mice
p
howev
reactiv
mice
inject
inocul
group
higher
mice
treat
group
c
day
inocul
p
l
hepat
necrosi
accompani
foliicular
lymphocyt
infiltr
mani
macrophag
mous
surviv
inject
day
infect
h
e
x
group
n
day
six
group
mice
still
aliv
data
express
mean
sem
intraperiton
inject
x
pfu
kill
mice
without
within
day
inject
mice
sever
haemorrhag
liver
necrosi
howev
high
surviv
rate
prolong
surviv
inject
inocul
group
show
significantli
higher
reactiv
mice
treat
group
c
day
mice
sacrif
day
inject
valu
express
subtract
reactiv
medium
cultur
group
c
also
control
n
data
express
mean
sem
p
use
student
ttest
studi
mice
treat
prior
inject
show
augment
b
cell
prolifer
respons
mitogen
result
protect
fulmin
infect
immunosuppress
effect
b
cell
given
surviv
mice
group
may
also
thought
inject
previous
augment
activ
intraperiton
macrophag
lymphocyt
reticuloendotheli
system
includ
kupffer
cell
follow
releas
interferon
antivir
agent
data
shown
known
strong
interferon
induc
activ
macrophag
might
inhibit
viral
prolifer
periton
caviti
rapidli
mediat
cell
activ
celldepend
antibodi
product
b
larg
amount
thought
remov
protect
mechan
aliv
virus
invad
system
circul
liver
may
inactiv
hand
suggest
group
b
e
inject
inocul
inject
success
suppress
prolifer
virus
alreadi
propag
diffus
liver
fulmin
hepat
develop
h
e
protect
effect
recombin
interleukin
interleukin
fulmin
hepat
also
investig
howev
success
result
obtain
unpubl
data
clear
preinject
protect
mice
fulmin
hepat
although
mechan
remain
unclear
fact
suggest
immunotherapi
might
introduc
fulmin
hepat
human
h
e
mechan
protect
effect
studi
greater
detail
